Diabetes

Maternal hyperglycemia ups offspring cardiometabolic risk

(HealthDay)—Maternal hyperglycemia during pregnancy is associated with increased risk of abnormal glucose tolerance, obesity, and increased blood pressure (BP) in offspring, independent of maternal obesity, according to ...

Diabetes

Sliding scale insulin order sheet cuts medication errors

(HealthDay)—A standardized sliding scale insulin (SSI) order sheet can reduce the incidence of SSI-related medication errors, according to a study published online Dec. 7 in the Journal of Evaluation in Clinical Practice.

Health

Famine alters metabolism for successive generations

The increased risk of hyperglycemia associated with prenatal exposure to famine is also passed down to the next generation, according to a new study of hundreds of families affected by widespread starvation in mid-20th Century ...

Diabetes

Sleep duration, efficiency linked to inpatient hyperglycemia

(HealthDay)—For hospitalized patients, additional sleep and increased sleep efficiency correlate with lower odds of hyperglycemia and impaired fasting glucose, according to research published online Nov. 30 in Diabetes ...

Diabetes

Metformin, sitagliptin prolong normoglycemia remission in DKA

(HealthDay)—For patients with new-onset diabetic ketoacidosis (DKA) and severe hyperglycemia, metformin and sitagliptin treatment after normoglycemia remission correlate with increased relapse-free survival and prolonged ...

Diabetes

Glucose levels linked to cardiac surgery outcomes

(HealthDay)—For patients undergoing cardiac surgery, hyperglycemia is associated with worse outcomes for patients without diabetes, but with better outcomes for patients with insulin-treated diabetes, according to a study ...

Diabetes

Maternal hyperglycemia not linked to obesity in offspring

(HealthDay)—Maternal hyperglycemia seems not to be a risk factor for obesity in offspring aged 5 to 7 years after adjustment for maternal body mass index (BMI), according to a study published online June 19 in Diabetes ...

Diabetes

Glucagon, GLP-1 co-infusion can reduce appetite

(HealthDay)—Co-infusion of glucagon and glucagon-like peptide 1 (GLP-1) correlates with a reduction in appetite, and GLP-1 protects against glucagon-induced hyperglycemia in healthy volunteers, according to a study published ...

page 2 from 5